15-Year Study Finds Treatment Gaps Exist for Patients with Peripheral Arterial Disease; More Consistent Use of Life-Saving Medications Recommended

A new 15-year study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that patients with peripheral arterial disease may not be prescribed life-saving medications at the same rate as for other heart conditions.

Omega-3 Continues to Show Protection Against Heart Disease-Related Death, Without Prostate Cancer Risk

Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health. That’s why researchers at the Intermountain Healthcare Heart Institute continue to research the potential benefits and risks of this popular supplement, especially when it comes to prostate cancer risk and heart health.

Researchers Discover New Mutations in Gene Associated with Disease That Causes Weakening of the Heart

Researchers from the Intermountain Healthcare Heart Institute in Salt Lake City have identified new mutations in a gene commonly associated with non-ischemic dilated cardiomyopathy (NIDC), a disease that weakens the heart muscle, making it more difficult to adequately circulate blood to meet the body’s needs.